Carbon monoxide

Intervention1 paper1 finding

C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.

1 lab in 1 country
  • Humans1

Associations

1

Cardiovascular-kidney-metabolic syndrome

upin humans1OR 1.12

1 study
  1. Carbon monoxide raises the risk of cardiovascular-kidney-metabolic syndrome in humans (OR 1.12, 95% CI 1.03–1.23).

    Humansn = 7,569

    The association between carbon monoxide and cardiovascular-kidney-metabolic syndrome in the Chinese populations: China Health and Retirement Longitudinal Study · Journal of nephrology · 28 Aug 2026

Cardiovascular-kidney-metabolic syndrome →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01